Treatment of restless legs syndrome with gabapentin

Clinical Neuropharmacology

Volumn 20, Issue 2, 1997, Pages 148-151

  Adler, Charles H ^a  

^a MAYO CLINIC   (United States)

Author keywords

Gabapentin; Movement disorders; Restless legs syndrome

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN;

ADULT; AGED; ANTICONVULSANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME;

EID: 0030898703     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199704000-00006     Document Type: Article

References (13)

1. Walters AS, Hening W. Review of the clinical presentation and neuropharmacology of restless legs syndrome. Clin Neuropharmacol 1987;10:225-37.
2. Walters AS, Hening WA, Chokroverty S. Review and videotape recognition of idiopathic restless legs syndrome. Mov Disord 1991;6:105-10.
3. Beydoun A, Uthman BM, Sackellares JC. Gabapentin: pharmacokinetics, efficacy, and safety. Clin Neuropharmacol 1995;18:469-81.
4. O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing 1994;3:200-3.
5. Brodeur C, Montplaisir J, Godbout R, Marinier R. Treatment of restless legs syndrome and periodic movements of sleep with l-dopa: a double-blind, controlled study. Neurology 1988;38:1845-8.
6. Guilleminault C, Cetel M, Philip P. Dopaminergic treatment of restless legs and rebound phenomenon. Neurology 1943;43:445.
7. Loscher W, Honack D, Taylor CP. Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions in rat brain. Neurosci Lett 1991;128:150-4.
8. 3H) gabapentin binding to a novel site in rat brain: homogenate binding studies. Eur J Pharmacol 1993;244:293-301.
9. Rao ML, Clarenbach P, Vahlensieck M, Dratzschmar S. Gabapentin augments whole blood serotonin in healthy young men. J Neurol Transm 1988;73:129-34.
10. Reimann W. Inhibition by GABA, baclofen, and gabapentin of dopamine release from rabbit caudate nucleus: are there common or different sites of action? Eur J Pharmacol 1983;94:341-4.
11. Schlicker E, Reimann W, Gothert M. Gabapentin deceases monoamine release without affecting acetylcholine release in the brain. Drug Res 1985;35:1347-9.
12. Mellick GA, Mellick LB. Management of restless legs syndrome with gabapentin (Neurontin). Sleep 1996;19:224-6.
13. Patel J, Naritoku DK. Gabapentin for the treatment of hemifacial spasm. Clin Neuropharmacol 1996;19:185-8.